phosphoserine has been researched along with miltefosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brachwitz, H; Grunicke, HH; Kindler, E; Maly, K; Schubert, C; Stekar, J; Uberall, F | 1 |
| Bergmann, J; Brachwitz, H; Langen, P; Thomas, Y | 1 |
2 other study(ies) available for phosphoserine and miltefosine
| Article | Year |
|---|---|
Cellular signalling as a target in cancer chemotherapy. Phospholipid analogues as inhibitors of mitogenic signal transduction.
Topics: Antineoplastic Agents; Calcium; Enzyme Inhibitors; Inositol 1,4,5-Trisphosphate; Molecular Structure; Neoplasms; Phospholipase D; Phospholipids; Phosphorylcholine; Phosphoserine; Protein Kinase C; Signal Transduction; Sodium-Hydrogen Exchangers; Thrombin; Type C Phospholipases | 1996 |
Opposite effects on cytosolic Ca2+ of antitumor phospholipids by induction of calcium influx and activation of endoplasmic reticulum Ca(2+)-ATPase.
Topics: Antineoplastic Agents; Breast; Calcium; Calcium-Transporting ATPases; Cell Division; Cell Line, Transformed; Cytarabine; Cytosol; Endoplasmic Reticulum; Enzyme Activation; Epithelial Cells; Female; Humans; Ion Transport; Lysophospholipids; Manganese; Phosphorylcholine; Phosphoserine; Signal Transduction; Structure-Activity Relationship | 1998 |